tiprankstipranks
Trending News
More News >
Tonix Pharma (TNXP)
NASDAQ:TNXP
US Market

Tonix Pharma (TNXP) Ratios

Compare
4,489 Followers

Tonix Pharma Ratios

TNXP's free cash flow for Q4 2024 was $0.54. For the 2024 fiscal year, TNXP's free cash flow was decreased by $ and operating cash flow was $-8.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.50 2.53 7.19 8.71 8.96
Quick Ratio
6.04 1.78 7.64 9.06 9.74
Cash Ratio
5.40 1.32 6.61 8.23 7.85
Solvency Ratio
-5.43 -2.30 -6.25 -4.16 -4.95
Operating Cash Flow Ratio
-3.33 -5.40 -5.39 -3.48 -4.95
Short-Term Operating Cash Flow Coverage
-19.69 -43.41 0.00 0.00 0.00
Net Current Asset Value
$ 95.67M$ -1.16M$ 112.27M$ 166.87M$ 77.45M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.06 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.06 0.09 <0.01 <0.01 0.01
Debt-to-Capital Ratio
0.05 0.09 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.03 0.06 0.00 0.00 0.00
Financial Leverage Ratio
1.17 1.46 1.09 1.10 1.12
Debt Service Coverage Ratio
-23.18 -48.55 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.33 0.01 0.00 0.00 0.00
Interest Debt Per Share
11.03 18.43 4.16 16.79 88.70
Net Debt to EBITDA
1.26 0.13 1.08 1.93 1.50
Profitability Margins
Gross Profit Margin
23.07%38.97%0.00%0.00%0.00%
EBIT Margin
-744.50%-1523.94%0.00%0.00%0.00%
EBITDA Margin
-710.61%-1468.70%0.00%0.00%0.00%
Operating Profit Margin
-1354.28%-1523.94%0.00%0.00%0.00%
Pretax Profit Margin
-1288.25%-1501.78%0.00%0.00%0.00%
Net Profit Margin
-1288.25%-1501.78%0.00%0.00%0.00%
Continuous Operations Profit Margin
-1288.25%-1501.78%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%106.04%100.00%103.39%
EBT Per EBIT
95.12%98.55%98.33%99.97%99.90%
Return on Assets (ROA)
-79.83%-75.53%-51.79%-38.31%-53.14%
Return on Equity (ROE)
-93.18%-110.55%-56.41%-42.19%-59.53%
Return on Capital Employed (ROCE)
-94.55%-87.32%-54.02%-42.12%-57.16%
Return on Invested Capital (ROIC)
-92.57%-85.66%-56.25%-41.99%-56.70%
Return on Tangible Assets
-79.89%-81.15%-51.81%-38.33%-53.20%
Earnings Yield
-535.47%-16.99%-8.21%-0.71%-0.82%
Efficiency Ratios
Receivables Turnover
1.25 1.69 0.00 0.00 0.00
Payables Turnover
1.71 1.25 13.89 6.95 10.99
Inventory Turnover
0.92 0.34 -13.94 -11.95 -6.62
Fixed Asset Turnover
0.24 0.08 0.00 0.00 0.00
Asset Turnover
0.06 0.05 0.00 0.00 0.00
Working Capital Turnover Ratio
0.16 0.11 0.00 0.00 0.00
Cash Conversion Cycle
473.85 1.01K -52.46 -83.07 -88.34
Days of Sales Outstanding
292.32 215.67 0.00 0.00 0.00
Days of Inventory Outstanding
395.22 1.09K -26.19 -30.55 -55.11
Days of Payables Outstanding
213.69 291.17 26.27 52.52 33.23
Operating Cycle
687.54 1.30K -26.19 -30.55 -55.11
Cash Flow Ratios
Operating Cash Flow Per Share
-82.74 -191.56 -537.14 -1.33K -3.29K
Free Cash Flow Per Share
-82.90 -206.39 -800.90 -1.95K -3.87K
CapEx Per Share
0.16 14.83 263.75 620.11 579.43
Free Cash Flow to Operating Cash Flow
1.00 1.08 1.49 1.47 1.18
Dividend Paid and CapEx Coverage Ratio
-507.71 -12.92 -1.79 -2.14 -5.39
Capital Expenditure Coverage Ratio
-507.71 -12.92 -2.04 -2.14 -5.67
Operating Cash Flow Coverage Ratio
-7.50 -10.39 -129.02 -79.03 -37.05
Operating Cash Flow to Sales Ratio
-6.04 -13.13 0.00 0.00 0.00
Free Cash Flow Yield
-251.37%-16.00%-10.27%-0.85%-0.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.19 -5.89 -12.18 -141.24 -122.38
Price-to-Sales (P/S) Ratio
2.41 88.40 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
0.17 6.51 6.87 59.60 72.85
Price-to-Free Cash Flow (P/FCF) Ratio
-0.40 -6.25 -9.73 -117.57 -111.76
Price-to-Operating Cash Flow Ratio
-0.40 -6.73 -14.51 -172.51 -131.47
Price-to-Earnings Growth (PEG) Ratio
<0.01 0.09 0.20 2.61 0.00
Price-to-Fair Value
0.17 6.51 6.87 59.60 72.85
Enterprise Value Multiple
0.93 -5.89 -11.76 -139.35 -124.97
EV to EBITDA
0.93 -5.89 -11.76 -139.35 -124.97
EV to Sales
-6.58 86.45 0.00 0.00 0.00
EV to Free Cash Flow
1.09 -6.11 -8.92 -115.97 -110.44
EV to Operating Cash Flow
1.09 -6.58 -13.30 -170.16 -129.91
Tangible Book Value Per Share
189.37 178.07 1.13K 3.84K 5.92K
Shareholders’ Equity Per Share
189.53 198.18 1.13K 3.84K 5.93K
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.04 <0.01 <0.01
Revenue Per Share
13.71 14.59 0.00 0.00 0.00
Net Income Per Share
-176.60 -219.09 -640.26 -1.62K -3.53K
Tax Burden
1.00 1.00 1.06 1.00 1.03
Interest Burden
1.73 0.99 0.98 1.00 1.00
Research & Development to Revenue
3.96 11.16 0.00 0.00 0.00
SG&A to Revenue
0.00 4.47 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.47 1.19 0.00 0.00 0.00
Income Quality
0.47 0.87 0.89 0.82 0.96
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis